Srinath, Archita
Nakamura, Akihiro http://orcid.org/0000-0002-4258-1603
Haroon, Nigil http://orcid.org/0000-0003-3210-4771
Article History
Accepted: 21 January 2024
First Online: 7 February 2024
Declarations
:
: A.N. has received a speaking honorarium from AbbVie and Novartis. N.H. has received consulting fees from Abbvie, Amgen, Eli Lilly, Janssen, Merck, Novartis and UCB.
: The authors declare no competing interests.
: This article does not contain any studies with human or animal subjects performed by any of the authors.